Symbol
BCTX on Nasdaq
Investment type
Equity / Common Stock, $0.01 par value
Latest Disclosed Ownership
190K shares
Security Ownership
4.9%

3i, LP ownership in BriaCell Therapeutics Corp. Common Stock, $0.01 par value (BCTX)

2025-05-13 - 3i, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 190K shares of BriaCell Therapeutics Corp. Common Stock, $0.01 par value (BCTX). This represents 4.9% percent ownership of the company. In their previous filing dated 2025-02-10, 3i, LP had reported owning 369K shares, indicating a decrease of -48.5% percent.